Skip to main content

Pfizer to test freeze-dried COVID-19 vaccine that doesn’t need ultracold storage

Pfizer Inc. and partner BioNTech SE plan to begin soon testing a freeze-dried version of its Covid-19 vaccine, which if proven to work safely could ease storage and handling of the shots in rural U.S. areas and low-income countries.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.